Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2000;87:833-834

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Epstein, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Epstein, J. A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Congenital Heart Defects
Related Collections
Right arrow Genetically altered mice
Right arrow Cardiac development
Right arrow Genetics of cardiovascular disease
(Circulation Research. 2000;87:833.)
© 2000 American Heart Association, Inc.


Editorial

Developmental Cardiology Comes of Age

Jonathan A. Epstein

From the University of Pennsylvania, Philadelphia, Pa.

Correspondence to Jonathan A. Epstein, University of Pennsylvania, 954 BRB II, 421 Curie Blvd, Philadelphia, PA 19104. E-mail epsteinj@mail.med.upenn.edu


Key Words: congenital heart disease • tinmanNkx2.5 • atrial septal defect


*    Introduction
 
Over the last 10 years, significant progress has been made in the understanding of molecular and genetic determinants of heart formation. An ever growing number of genes have been identified that are required for cardiogenesis, as evidenced by severe abnormalities in cardiac development produced by inactivation in the mouse or inhibition of gene function in other model organisms.1 In general, scientists have identified these genes because of their expression in early cardiac tissues or because of the severe phenotype produced by mutation or inactivation. Gross abnormalities of cardiac development lead to embryonic demise either during midgestation or in the peripartum period, and the underlying severe defects in cardiac structure or function have been relatively easy to determine and describe.1 2 3 Similar defects in the human versions of these genes may account for embryonic lethal forms of human congenital heart disease. It has been hypothesized that hypomorphic mutations or reduction in gene dosage may result in less severe forms of congenital heart disease, such as those seen in surviving newborns and adults. Alternatively, clinically relevant cardiovascular developmental defects affecting infants and adults generally may result from mutations in genes entirely unrelated to those critical during early stages of cardiac specification and heart morphogenesis, making these factors less attractive for intensive study as disease-causing genes. Data to support the former hypothesis have recently come to light.

Perhaps the most intriguing example comes from the study of a mammalian homologue of a gene first described in the fruit fly, Drosophila melanogaster. This organism . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Reproductive SciencesHome page
L. Zhang
Prenatal Hypoxia and Cardiac Programming
Reproductive Sciences, January 1, 2005; 12(1): 2 - 13.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
G. Li, Y. Xiao, J. L. Estrella, C. A. Ducsay, R. D. Gilbert, and L. Zhang
Effect of Fetal Hypoxia on Heart Susceptibility to Ischemia and Reperfusion Injury in the Adult Rat
Reproductive Sciences, July 1, 2003; 10(5): 265 - 274.
[Abstract] [PDF]